1. Home
  2. VRME vs CERO Comparison

VRME vs CERO Comparison

Compare VRME & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRME
  • CERO
  • Stock Information
  • Founded
  • VRME 1999
  • CERO 2017
  • Country
  • VRME United States
  • CERO United States
  • Employees
  • VRME N/A
  • CERO N/A
  • Industry
  • VRME EDP Services
  • CERO
  • Sector
  • VRME Technology
  • CERO
  • Exchange
  • VRME Nasdaq
  • CERO Nasdaq
  • Market Cap
  • VRME 11.2M
  • CERO 9.6M
  • IPO Year
  • VRME N/A
  • CERO N/A
  • Fundamental
  • Price
  • VRME $0.97
  • CERO $8.25
  • Analyst Decision
  • VRME Strong Buy
  • CERO Strong Buy
  • Analyst Count
  • VRME 2
  • CERO 2
  • Target Price
  • VRME $1.50
  • CERO $45.00
  • AVG Volume (30 Days)
  • VRME 10.1M
  • CERO 41.3K
  • Earning Date
  • VRME 08-13-2025
  • CERO 08-22-2025
  • Dividend Yield
  • VRME N/A
  • CERO N/A
  • EPS Growth
  • VRME N/A
  • CERO N/A
  • EPS
  • VRME N/A
  • CERO N/A
  • Revenue
  • VRME $22,071,000.00
  • CERO N/A
  • Revenue This Year
  • VRME N/A
  • CERO N/A
  • Revenue Next Year
  • VRME $5.93
  • CERO N/A
  • P/E Ratio
  • VRME N/A
  • CERO N/A
  • Revenue Growth
  • VRME N/A
  • CERO N/A
  • 52 Week Low
  • VRME $0.55
  • CERO $6.71
  • 52 Week High
  • VRME $5.00
  • CERO $895.40
  • Technical
  • Relative Strength Index (RSI)
  • VRME 55.55
  • CERO 49.24
  • Support Level
  • VRME $0.80
  • CERO $8.07
  • Resistance Level
  • VRME $0.96
  • CERO $8.90
  • Average True Range (ATR)
  • VRME 0.09
  • CERO 0.40
  • MACD
  • VRME -0.00
  • CERO 0.11
  • Stochastic Oscillator
  • VRME 63.25
  • CERO 59.38

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.

Share on Social Networks: